Twin Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $812K | Buy |
+4,430
| New | +$816K | 0.1% | 187 |
|
|
2025
Q4 | – | Sell |
-6,788
| Closed | -$951K | – | 253 |
|
|
2025
Q3 | $951K | Sell |
6,788
-5,246
| -44% | -$709K | 0.12% | 168 |
|
|
2025
Q2 | $1.51M | Buy |
12,034
+492
| +4% | +$61.3K | 0.16% | 148 |
|
|
2025
Q1 | $1.58M | Buy |
11,542
+3,029
| +36% | +$433K | 0.18% | 133 |
|
|
2024
Q4 | $1.3M | Buy |
8,513
+63
| +0.7% | +$10.6K | 0.14% | 147 |
|
|
2024
Q3 | $1.64M | Sell |
8,450
-68
| -0.8% | -$14.2K | 0.18% | 140 |
|
|
2024
Q2 | $1.97M | Buy |
8,518
+260
| +3% | +$56.5K | 0.23% | 121 |
|
|
2024
Q1 | $1.78M | Sell |
8,258
-593
| -7% | -$139K | 0.22% | 128 |
|
|
2023
Q4 | $2.29M | Sell |
8,851
-278
| -3% | -$68.3K | 0.3% | 101 |
|
|
2023
Q3 | $2.35M | Sell |
9,129
-534
| -6% | -$143K | 0.34% | 86 |
|
|
2023
Q2 | $2.75M | Sell |
9,663
-359
| -4% | -$107K | 0.36% | 73 |
|
|
2023
Q1 | $2.79M | Sell |
10,022
-1,558
| -13% | -$431K | 0.38% | 79 |
|
|
2022
Q4 | $3.21M | Buy |
11,580
+1,830
| +19% | +$517K | 0.42% | 70 |
|
|
2022
Q3 | $2.6M | Buy |
+9,750
| New | +$2.07M | 0.35% | 81 |
|
|
2021
Q4 | – | Sell |
-1,547
| Closed | -$438K | – | 284 |
|
|
2021
Q3 | $438K | Buy |
1,547
+18
| +1% | +$5.9K | 0.04% | 279 |
|
|
2021
Q2 | $529K | Hold |
1,529
| – | – | 0.05% | 262 |
|
|
2021
Q1 | $428K | Sell |
1,529
-11,298
| -88% | -$3.05M | 0.04% | 280 |
|
|
2020
Q4 | $3.14M | Sell |
12,827
-388
| -3% | -$100K | 0.29% | 107 |
|
|
2020
Q3 | $3.75M | Sell |
13,215
-171
| -1% | -$47.7K | 0.34% | 87 |
|
|
2020
Q2 | $3.58M | Sell |
13,386
-943
| -7% | -$283K | 0.34% | 90 |
|
|
2020
Q1 | $4.53M | Buy |
14,329
+10
| +0.1% | +$3.04K | 0.49% | 56 |
|
|
2019
Q4 | $4.25M | Sell |
14,319
-2,200
| -13% | -$610K | 0.36% | 93 |
|
|
2019
Q3 | $3.85M | Sell |
16,519
-1,110
| -6% | -$258K | 0.28% | 121 |
|
|
2019
Q2 | $4.12M | Sell |
17,629
-10,335
| -37% | -$2.39M | 0.29% | 120 |
|
|
2019
Q1 | $6.61M | Buy |
27,964
+70
| +0.3% | +$22K | 0.33% | 98 |
|
|
2018
Q4 | $8.39M | Sell |
27,894
-1,516
| -5% | -$484K | 0.47% | 63 |
|
|
2018
Q3 | $10.4M | Buy |
29,410
+2,270
| +8% | +$782K | 0.48% | 59 |
|
|
2018
Q2 | $7.88M | Buy |
27,140
+340
| +1% | +$95.6K | 0.4% | 80 |
|
|
2018
Q1 | $7.34M | Sell |
26,800
-7,522
| -22% | -$2.33M | 0.38% | 88 |
|
|
2017
Q4 | $10.9M | Buy |
34,322
+8,302
| +32% | +$2.66M | 0.54% | 53 |
|
|
2017
Q3 | $8.15M | Buy |
26,020
+2,590
| +11% | +$767K | 0.43% | 71 |
|
|
2017
Q2 | $6.36M | Buy |
23,430
+1,180
| +5% | +$312K | 0.37% | 80 |
|
|
2017
Q1 | $6.08M | Sell |
22,250
-8,041
| -27% | -$2.27M | 0.38% | 82 |
|
|
2016
Q4 | $8.59M | Sell |
30,291
-2,226
| -7% | -$660K | 0.55% | 48 |
|
|
2016
Q3 | $10.2M | Buy |
32,517
+17,537
| +117% | +$5.19M | 0.68% | 33 |
|
|
2016
Q2 | $3.62M | Sell |
14,980
-900
| -6% | -$237K | 0.27% | 118 |
|
|
2016
Q1 | $4.13M | Buy |
15,880
+760
| +5% | +$201K | 0.32% | 92 |
|
|
2015
Q4 | $4.63M | Buy |
15,120
+1,300
| +9% | +$374K | 0.38% | 74 |
|
|
2015
Q3 | $4.03M | Buy |
13,820
+250
| +2% | +$82.6K | 0.38% | 77 |
|
|
2015
Q2 | $5.48M | Sell |
13,570
-4,580
| -25% | -$1.84M | 0.49% | 62 |
|
|
2015
Q1 | $7.66M | Buy |
18,150
+820
| +5% | +$323K | 0.67% | 38 |
|
|
2014
Q4 | $5.88M | Buy |
17,330
+670
| +4% | +$217K | 0.56% | 51 |
|
|
2014
Q3 | $5.51M | Buy |
16,660
+1,511
| +10% | +$498K | 0.56% | 43 |
|
|
2014
Q2 | $4.78M | Buy |
15,149
+2,780
| +22% | +$837K | 0.48% | 52 |
|
|
2014
Q1 | $3.78M | Sell |
12,369
-100
| -0.8% | -$31.7K | 0.4% | 69 |
|
|
2013
Q4 | $3.49M | Buy |
12,469
+100
| +0.8% | +$25.9K | 0.37% | 79 |
|
|
2013
Q3 | $2.98M | Buy |
12,369
+650
| +6% | +$145K | 0.32% | 98 |
|
|
2013
Q2 | $2.52M | Buy |
+11,719
| New | +$2.5M | 0.27% | 111 |
|
Other funds holding BIIB
VCM
VPM
Twin Capital Management's BIIB Position: Q1 2026 in Review
Twin Capital Management opened a new position in Biogen (BIIB) in Q1 2026: 4,430 shares worth $812K. The stake represents 0.1% of the portfolio and ranks #187 among its holdings. This is a return to the name: Twin Capital Management previously reported a position in BIIB as recently as Q3 2025.
Twin Capital Management first reported a position in BIIB in Q2 2013 and has held it in 48 quarters since. The position peaked at $10.9M in Q4 2017. 1,004 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Twin Capital Management held 4,430 shares of Biogen worth $812K as of Q1 2026.
- Biogen was a new Twin Capital Management position in Q1 2026.
- Biogen made up 0.1% of Twin Capital Management's portfolio in Q1 2026, its #187 holding.
- Twin Capital Management first reported a position in Biogen in Q2 2013 and has held it in 48 quarters since.
- Twin Capital Management's Biogen position peaked at $10.9M in Q4 2017.
- 1,004 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Twin Capital Management's 13F filing for Q1 2026, filed 5 May 2026.